Clinical Trials of Monoclonal Antibodies to Prevent Covid-19 Enrolling
All trial participants will be followed for safety for seven months after efficacy assessment period ends. Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…